1. Home
  2. CENTA vs MLYS Comparison

CENTA vs MLYS Comparison

Compare CENTA & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company Nonvoting

CENTA

Central Garden & Pet Company Nonvoting

HOLD

Current Price

$33.87

Market Cap

2.0B

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$25.87

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENTA
MLYS
Founded
1955
2019
Country
United States
United States
Employees
6000
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
CENTA
MLYS
Price
$33.87
$25.87
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$36.75
$48.67
AVG Volume (30 Days)
229.9K
1.1M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.60
N/A
Revenue Next Year
$2.04
N/A
P/E Ratio
$13.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.97
$12.59
52 Week High
$37.35
$47.65

Technical Indicators

Market Signals
Indicator
CENTA
MLYS
Relative Strength Index (RSI) 54.40 41.60
Support Level $31.16 $22.42
Resistance Level $35.12 $31.19
Average True Range (ATR) 0.84 1.63
MACD 0.04 -0.24
Stochastic Oscillator 50.75 6.56

Price Performance

Historical Comparison
CENTA
MLYS

About CENTA Central Garden & Pet Company Nonvoting

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: